Harbor Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Harbor Advisory's PFE Position: Q3 2026 in Review
Harbor Advisory increased its Pfizer (PFE) stake by 0.02% in Q3 2026, buying an estimated $1.06K and bringing the position to 171,068 shares worth $4.88M. The position accounts for 1.3% of the portfolio, ranked #27.
Harbor Advisory first reported a position in PFE in Q2 2021 and has held it in 22 quarters since. The position peaked at $5.3M in Q4 2022. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Harbor Advisory held 171,068 shares of Pfizer worth $4.88M as of Q3 2026.
- Harbor Advisory bought 40 Pfizer shares in Q3 2026, an estimated $1.06K.
- Pfizer made up 1.3% of Harbor Advisory's portfolio in Q3 2026, its #27 holding.
- Harbor Advisory first reported a position in Pfizer in Q2 2021 and has held it in 22 quarters since.
- Harbor Advisory's Pfizer position peaked at $5.3M in Q4 2022.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Harbor Advisory's 13F filing for Q3 2026, filed 13 Nov 2026.